Chemocentryx Inc (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,114 | 68,752 | 30,550 | 40,020 | 17,961 |
| Marketable Securities | 149,004 | 113,289 | 116,018 | 87,271 | 102,603 |
| Receivables | 336 | 164 | 1,698 | 51,090 | 530 |
| TOTAL | $176,067 | $184,925 | $149,798 | $179,830 | $122,393 |
| Non-Current Assets | |||||
| PPE Net | 1,594 | 1,614 | 1,131 | 1,210 | 970 |
| Investments And Advances | 12,878 | 19,765 | 30,508 | 7,929 | 4,204 |
| Other Non-Current Assets | 222 | 306 | 327 | 359 | 381 |
| TOTAL | $14,694 | $21,685 | $31,966 | $9,498 | $5,555 |
| Total Assets | $190,761 | $206,610 | $181,764 | $189,328 | $127,948 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 576 | 1,022 | 449 | 1,400 | 1,353 |
| Accrued Expenses | 11,727 | 11,018 | 7,195 | 8,575 | 8,185 |
| TOTAL | $61,328 | $68,708 | $76,641 | $32,937 | $44,410 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,727 | 14,700 | 4,700 | 4,676 | N/A |
| Deferred Revenues | 49,025 | 56,668 | 68,997 | 22,962 | 34,872 |
| Other Non-Current Liabilities | 425 | 419 | 337 | 251 | 214 |
| TOTAL | $107,961 | $109,004 | $79,591 | $77,124 | $46,241 |
| Total Liabilities | $169,289 | $177,712 | $156,232 | $110,061 | $90,651 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,526 | 50,379 | 49,150 | 48,921 | 48,767 |
| Common Shares | 50 | 50 | 49 | 49 | 49 |
| Retained earnings | -363,712 | -352,822 | -345,948 | -289,200 | -328,855 |
| Other shareholders' equity | -205 | -253 | -318 | -135 | -84 |
| TOTAL | $21,472 | $28,898 | $25,532 | $79,267 | $37,297 |
| Total Liabilities And Equity | $190,761 | $206,610 | $181,764 | $189,328 | $127,948 |